TY - JOUR
TI - RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
AU - Cherny, N.I.
AU - Dafni, U.
AU - Bogaerts, J.
AU - Latino, N.J.
AU - Pentheroudakis, G.
AU - Douillard, J.-Y.
AU - Tabernero, J.
AU - Zielinski, C.
AU - Piccart, M.J.
AU - de Vries, E.G.E.
JO - Journal of the National Cancer Institute. Monographs
PY - 2018
VL - 110
TODO - 10
SP - 1142-1143
PB - NLM (Medline)
SN - 1052-6773
TODO - 10.1093/jnci/djy029
TODO - antineoplastic agent, drug approval;  Food and Drug Administration;  United States, Antineoplastic Agents;  Drug Approval;  United States;  United States Food and Drug Administration
TODO - null
ER -